SHALABY, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 2.001
AS - Asia 403
EU - Europa 332
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.744
Nazione #
US - Stati Uniti d'America 1.998
CN - Cina 190
SG - Singapore 174
IT - Italia 142
DE - Germania 39
FI - Finlandia 29
SE - Svezia 27
IN - India 26
FR - Francia 24
GB - Regno Unito 21
IE - Irlanda 11
ES - Italia 9
NL - Olanda 9
RU - Federazione Russa 5
RO - Romania 4
CA - Canada 3
HK - Hong Kong 3
PL - Polonia 3
UA - Ucraina 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
ET - Etiopia 2
RS - Serbia 2
TR - Turchia 2
BD - Bangladesh 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 2.744
Città #
Fairfield 331
Chandler 168
Woodbridge 158
Ashburn 150
Singapore 145
Seattle 134
Houston 124
Cambridge 119
Wilmington 93
Ann Arbor 81
Santa Clara 80
Boardman 61
San Diego 56
Beijing 46
Padova 41
Medford 34
Princeton 34
Des Moines 26
Helsinki 24
Pune 22
Roxbury 20
Guangzhou 17
Dearborn 11
Dublin 11
Milan 11
Nanjing 11
Shanghai 10
Hefei 9
Bologna 7
London 7
Jinan 6
New York 6
Los Angeles 5
Rome 5
Rozzano 5
Shenyang 5
Trieste 5
Lappeenranta 4
Munich 4
Nanchang 4
Naples 4
Amsterdam 3
Biella 3
Frankfurt am Main 3
Fuzhou 3
Hangzhou 3
Hong Kong 3
Kilburn 3
Kunming 3
Lozzo Atestino 3
Málaga 3
Ogden 3
Phoenix 3
Pisa 3
Rizhao 3
Tianjin 3
Vinh 3
Addis Ababa 2
Anyang 2
Barcelona 2
Dallas 2
Esslingen am Neckar 2
Forlì 2
Hebei 2
Kharkiv 2
L’Aquila 2
Meana Sardo 2
Ningbo 2
Norwalk 2
Ospedaletto Euganeo 2
Pamplona 2
Piacenza 2
Redwood City 2
Tappahannock 2
Vienna 2
Washington 2
Weimar 2
Acton 1
Adliswil 1
Alexandria 1
Andover 1
Ankara 1
Auckland 1
Belgrade 1
Biassono 1
Boston 1
Brussels 1
Calgary 1
Campolongo 1
Changsha 1
Chaoyang 1
Charlotte 1
Chiswick 1
Chongqing 1
Clearwater 1
Falkenstein 1
Fenghua 1
Foggia 1
Granada 1
Guishan 1
Totale 2.205
Nome #
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 156
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 131
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 125
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 122
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 115
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 109
Management of bacterial infection in the liver transplant candidate 107
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 100
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 97
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014 93
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 91
Survival after the diagnosis of de novo malignancy in liver transplant recipients 91
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 91
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 88
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 86
Local prothrombotic state in portal venous system in cirrhosis 76
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 71
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 68
Management of portal hypertension severe complications 63
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 59
Long-term care of transplant recipients: de novo neoplasms after liver transplantation 55
Drug induced liver injury: from pathogenesis to liver transplantation 55
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 55
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 47
De novo and recurrent malignancy 46
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 42
Role of non-neoplastic portal vein thrombosis in the natural history of patients with cirrhosis and first diagnosis of hepatocellular carcinoma 41
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know 41
Reply 40
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 40
Malnourished cirrhotic patient: what should we do? 40
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 37
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 37
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 36
Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients 34
New indications for liver transplantation 32
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis 27
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 24
Vascular liver diseases: A sex-oriented analysis of the literature 21
Recent advances in the management of acute variceal hemorrhage 21
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 20
Ruolo prognostico della trombosi portale non neoplastica nel paziente cirrotico con epatocarcinoma 17
Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982](S074879832300032X)(10.1016/j.ejso.2023.01.010) 15
Hepatic venous pressure gradient in hepatic resection for hepatocellular carcinoma 14
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 14
Coagulation meets senescence in NASH! 10
Sex disparity and drug-induced liver injury 7
Totale 2.807
Categoria #
all - tutte 14.719
article - articoli 13.348
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020298 0 0 0 0 0 42 69 53 57 37 22 18
2020/2021350 15 22 25 23 6 21 15 30 38 55 36 64
2021/2022533 23 31 58 27 21 69 52 37 24 29 49 113
2022/2023380 63 33 9 39 67 44 11 31 48 3 27 5
2023/2024384 34 44 45 29 34 51 41 13 20 27 20 26
2024/2025435 2 121 48 80 146 38 0 0 0 0 0 0
Totale 2.807